Investigators trialed injection of an immune-stimulating substance (poly-ICLC) into the prostate gland using MRI-ultrasound fusion technology in patients scheduled to undergo radical prostatectomy.
Iowa and Indiana have recently introduced legislation that would establish new registration and licensure requirements for medical spas. Iowa ...
Physicians in the emergency department can use oral medications as first-line therapy for agitation, with sedation time and ...
CROSSJECT announces initiation of coverage of its stock by Portzamparc (BNP Paribas Group) ...
The Casppian study design included periodic evaluations and long-term safety monitoring for up to a total of 12 months following the first injection. -- There has been no safety concern with the use ...
The FDA approved Scancell's phase 3 trial of iSCIB1+ for advanced melanoma, focusing on progression-free survival as a ...
LIBERTY is part of the Company’s broader REVOLUTION clinical program designed to elaborate the profile of monoclonal antibody-mediated ...
Former Survivor contestant Teeny Chirichillo on the joy and stress of being a “very online” trans man.
Sometimes, you don’t need to think about your brain. It just… runs. You wake up, remember your passwords (mostly), answer ...
MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination with MSD’s PD-1 inhibitor Keytruda for patients with non-small cell lung cancer ...
Anaphylaxis triggered by iodinated contrast media was rare, but severe and refractory cases indicated the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results